Hypertension Clinical Trial
Official title:
Effect of Ambulatory BP Monitoring on the CliniCal coUrse and RenAl ouTcomE of Chronic Kidney Disease
Control of blood pressure (BP) is the first thing to do in the management of chronic kidney
disease (CKD). Although guidelines suggest the optimal blood pressure level, it is hard to
assess BP correctly during the office visit. Often there is a discrepancy between office BP
and out-of-office BP, including home BP and ambulatory BP. Recent study reported that as many
as 34% of Korean CKD patients had masked hypertension, which means high BP by ambulatory BP
monitoring but normal BP by conventional office BP measurement.
This study aims to evaluate the effect of ambulatory BP-guided BP management on the clinical
outcome of CKD, compared to the conventional management using office BP.
We hypothesized that management of blood pressure using ambulatory BP monitoring would obtain
more optimal BP control and thereby would influence positively on renal progression and CV
outcomes.
In detail, when the eligibility criteria is met, all the subjects will undergo both
ambulatory BP and office BP measurement at baseline.
After randomization, ARB (fimasartan) will be administered to drug-naive subjects or will
replace the other RAS blockers in subjects with current uses. Dosing of fimasartan will be
adjusted or additional drugs of other classes will be added sequentially over 3 months
(titration phase).
At 3 months, ABPM will be performed in ABPM group to evaluate the adequacy of blood pressure
control and dosing will be adjusted according to the ABPM results (target BP: daytime BP <
135/85 mm Hg). This adjustment will be assessed at 6 months by ABPM once again.
For subjects in office BP group, conventional care will be provided according to current
guidelines (target BP < 140/90 mm Hg).
At 18 months, ABPM will be performed in all the subjects and outcome measures will be
assessed.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |